Chemistry, Biological Activity, and Chemotherapeutic Potential of Betulinic Acid for the Prevention and Treatment of Cancer and HIV Infection

Medicinal Research Reviews

Volumn 24, Issue 1, 2004, Pages 90-114

  Cichewicz, Robert H ^a   Kouzi, Samir A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Anti inflammatory; Betulin; Betulinic acid; Cancer; HIV; Pentacyclic lupane type triterpene; Synthesis

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BETULIC ACID; GLYCOPROTEIN GP 41; PROTEIN P53; TRITERPENE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER PREVENTION; CANCER THERAPY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SELECTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MELANOMA CELL; MOUSE; NONHUMAN; REVIEW; VIRUS ASSEMBLY;

ANIMALS; ANTI-HIV AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HIV INFECTIONS; HUMANS; MASS SPECTROMETRY; NEOPLASMS; TRITERPENES;

EID: 0346881254     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.10053     Document Type: Review

References (121)

1. Connolly JD, Hill RA. Triterpenoids. Nat Prod Rep 2000;17:463-482.
2. Krasutsky PA, Carlson RM, Nesterenko VV, Kolomitsyn IV, Edwardson CF. Birch bark processing and isolation of natural products from birch bark. U.S. Patent 6,392,070; 2002.
3. Draeger B, Galgon T, Neubert R, Wohlra W. Method of producing betulinic acid by the fractional extraction of ground plane tree bark using dichloromethane. U.S. Patent 6,175,053; 2002.
4. Jaggi M, Ramadoss S, Rajendran P, Siddiqui MJA. Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives, and their use for treating tumor associated angiogenesis. U.S. Patent 6,403,816; 2002.
5. Debatin KM, Fulda S, Wiessier M, Los M, Mier W. Preparation of betulinic acid derivatives for pharmaceutical use in the treatment of neuroectodermal tumors. U.S. Patent 6,369,109; 2002.
6. Pezzuto JM, Das Gupta TK, Schimidt ML, Kuzmanoff KM, Ling-Indeck L, Kim DSHL. Method and composition using betulinic acid or a betulinic acid derivative for treating cancer. U.S. Patent 5,962,527; 1999.
7. Lee KH, Kashiwada Y, Hashimoto F, Cosentino LM, Manak M. Betulinic acid derivatives and antiviral use. U.S. Patent 5,679,826; 1997.
8. Bradbury JB, Schafer SJ, Kaczvinsky JR, Bailey D, Gale CD. Method for regulating hair growth. U.S. Patent 6,124,362; 2000.
9. Hayek EWH, Jordis U, Moche W, Sauter F. A bicentennial of betulin. Phytochemistry 1989;28:2229-2242.
10. O'Connell MM, Bently MD, Campbell CS, Cole BJW. Betulin and lupeol in bark from four white-barked birches. Phytochemistry 1988;27:2175-2176.
11. Cole BJW, Bentley MD, Hua Y. Triterpenoid extractives in the outer bark of Betula lenta (black birch). Holzforschung 1991;45:265-268.
12. Galgon T, Hoke D, Drager B. Identification and quantification of betulinic acid. Phytochem Anal 1999;10:187-190.
13. Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell AC, Beecher CWW, Fong HHS, Kinghorn AD, Brown DM, Wani MC, Wall ME, Hieken TJ, Das Gupta TK, Pezzuto JM. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1995;1:1046-1051.
14. Schuhly W, Heilmann J, Calis I, Sticher O. New triterpenoids with antibacterial activity from Zizyphus joazeiro. Planta Med 1999;65:740-743.
15. Jagadeesh SG, Krupadanam GLD, Srimannarayana G, Murthy SS, Kaur A, Raja SS. Tobacco caterpillar antifeedant from the gotti stem wood triterpene betulinic acid. J Agric Food Chem 1998;46:2797-2799.
16. Kashiwada Y, Wang HK, Nagao T, Kitanaka S, Yasuda I, Fujioka T, Yamagishi T, Cosentino LM, Kozuka M, Okabe H, Ikeshiro Y, Hu CQ, Yeh E, Lee KH. Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids. J Nat Prod 1998;61:1090-1095.
17. Chang CW, Wu TS, Hsieh YS, Kuo SC, Chao PDL. Terpenoids of Syzygium formosanum. J Nat Prod 1999;62:327-328.
18. Recio MC, Giner RM, Manez S, Gueho J, Julien HR, Hostettmann K, Rios JL. Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas. Planta Med 1995;61:9-12.
19. Higa M, Ogihara K, Yogi S. Bioactive naphthoquinone derivatives from Diospyros maritime Blume. Chem Pharm Bull 1998;46:1189-1193.
20. Singh P, Sharma S. Triterpenoid constituents of the seed of Diospyros melanoxylon, Tecomella undulata, and Terminalia bellirica. J Indian Chem Soc 1997;74:504-505.
21. Ikuta A, Kamiya K, Satake T, Saiki Y. Triterpenoids from callus tissue cultures of Paeonia species. Phytochemistry 1995;38:1203-1207.
22. Lin HC, Ding HY, Wu YC. Two novel compounds from Paeonia suffruticosa. J Nat Prod 1998;61:343-346.
23. Kamiya K, Yoshioka K, Saiki Y, Ikuta A, Satake T. Triterpenoids and flavonoids from Paeonia lactiflora. Phytochemistry 1997;44:141-144.
24. Kinoshita K, Akiba M, Saitoh M, Ye Y, Koyama K, Takahashi K, Kondo N, Yuasa H. Antinociceptive effect of triterpenes from cacti. Pharm Biol 1998;36:50-57.
25. Enwerem NM, Okogun JI, Wambebe CO, Okorie DA, Akah PA. Antihelmintic activity of the stem bark extracts of Berlina grandiflora and one of its active principles, betulinic acid. Phytomedicine 2001;8:112-114.
26. Ryu SY, Lee CK, Lee CO, Kim HS, Zee OP. Antiviral triterpenes from Prunella vulgaris. Arch Pharm Res 1992;15:242-245.
27. Macias FA, Simonet AM, Galindo JCG. Natural products that influence plant growth and development from plants: The case of Melilotus messanensis (L.) All. Proc. Growth Reg Soc Am 1995;22:53-57.
28. Sun HH, Kaplita PV, Houck DR, Stawicki MB, McGarry R, Wahl RC, Gillum AM, Cooper R. A metalloproteinase inhibitor from Doliocarpus verruculosus. Phytother Res 1996;10:194-197.
29. Zhu M, Phillipson JD, Greengrass PM, Bowery NG. Chemical and biological investigation of the root bark of Clerodendrum mandarinorum. Planta Med 1996;62:393-396.
30. Ryu SY, Oak M-H, Yoon S-K, Cho D-I, Yoo G-S, Kim T-S, Kim K-M. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med 2000;66:358-360.
31. Fulda S, Jeremias I, Steiner HH, Pietsch T, Debatin KM. Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells. Int J Cancer 1999;82:435-441.
32. Dunstan CA, Liu B, Welch CJ, Perera P, Bohlin L. Alphitol, a phenolic substance from Alphitonia zizyphoides which inhibits prostaglandin biosynthesis in vitro. Phytochemistry 1998;48:495-497.
33. Bringmann G, Saeb W, Assi LA, Francois G, Narayanan ASS, Peters K, Peters EM. Betulinic acid: Isolation from Triphyophyllum peltatum and Ancistrocladus heyneanus, antimalarial acitivity, and crystal structure of the benzyl ester. Planta Med 1997;63:255-257.
34. Peng C, Bodenhausen G, Qiu S, Fong HHS, Farnsworth NR, Yuan S, Zheng C. Computer-assisted structure elucidation: Application of CISOC-SES to the resonance assignment and structure generation of betulinic acid. Magn Reson Chem 1998;36:267-278.
35. Li JG, Wei XY, Wei BY. Chemical components of Spirea alpine. Chin J Bot 1992;4:157-160.
36. Kim DSHL, Chen Z, Nguyen VT, Pezzuto JM, Qui S, Lu Z-Z. A concise semi-synthetic approach to betulinic acid from betulin. Synth Commun 1997;27:1607-1612.
37. Sandberg F, Dutschewska H, Christov V, Spassov S. Spondianthus preussii var. glaber Engler: Pharmacological screening and occurrence of triterpenes. Acta Pharm Suec 1987;24:253-256.
38. Huang C, Tunon H, Bohlin L. Anti-inflammatory compounds isolated from Menyanthes trifoliata L. Acta Pharm Sinica 1995;30:621-626.
39. Mukherjee PK, Saha K, Das J, Pal M, Saha BP. Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta Med 1997;63:367-369.
40. Nick A, Wright AD, Rali T, Sticher O. Antibacterial triterpenoids from Dillenia papuana and their structure-activity relationships. Phytochemistry 1995;40:1691-1695.
41. Cinta Pinzaru S, Leopold N, Kiefer W. Vibrational spectroscopy of the HIV inhibitor betulinic acid and its birch bark natural source. Talanta 2002;57:625-631.
42. Kouzi SA, Chatterjee P, Pezzuto JM, Hamann MT. Microbial transformations of the antimelanoma agent betulinic acid. J Nat Prod 2000;63:1653-1657.
43. 13C-NMR spectra of pentacyclic triterpenoids-a compilation and some salient features. Phytochemistry 1994;37:1517-1575.
44. Shin YG, Cho KH, Chung SM, Graham J, Gupta TKD, Pezzuto JM. Determination of betulinic acid in mouse blood, tumor, and tissue homogenates by liquid chromatography-electrospray mass spectrometry. J Chromatogr B 1999;732:331-336.
45. Chatterjee P, Pezzuto JM, Kouzi SA. Glucosidation of betulinic acid by Cunninghamella species. J Nat Prod 1999;62:761-763.
46. Chatterjee P, Kouzi SA, Pezzuto JM, Hamann MT. Biotransformation of the antimelanoma agent betulinic acid by Bacillus megaterium ATCC 13368. Appl Environ Microbiol 2000;66:3850-3855.
47. Macias FA, Simonet AM, Galindo JCG, Pacheco PC, Sanchez JA. Bioactive polar triterpenoids from Melilotus messanensis. Phytochemistry 1998;49:709-717.
48. 3-dimethyl sulfide complex. Chem Nat Comp 1999;35:73-74.
49. Li T-S, Wang J-X, Zheng X-J. Simple synthesis of allobetulin, 28-oxyallobetulin, and related biomarkers from betulin and betulinic acid catalysed by solid acids. J Chem Soc Perkin Trans 1 1998;23: 3957-3965.
50. Reddy KD, Raj SKR, Ramaiah TSS, Rao VV, Nath AR. Oxidative decarboxylation-II: Oxidative decarboxylation of acetyl betulinic acid. Oxidative Commun 1987;10:305-312.
51. Yasue M, Sakakibara J, Kaiya T. Synthesis of nitrogen-containing triterpenes. III. Derivatives of betulinic acid and oleanolic acid. Yakugaku Zasshi 1974;94:1468-1474.
52. Deng Y, Snyder JK. Preparation of a 24-nor-1,4-dien-3-one triterpene derivative from betulin: A new route to 24-nortriterpene analogs. J Org Chem 2002;67:2864-2873.
53. Dinda B, Hajra AK, Das SK, Chel G, Chakraborty R, Ranu BC. Reactions on naturally occurring triterpenes: Part 1. Indian J Chem 1995;34B:624-628.
54. Kashiwada Y, Hashimoto F, Cosentino LM, Chen CH, Garrett PE, Lee KH. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. J Med Chem 1996;39:1016-1017.
55. Klinot J, Sumanova V, Vystrcil A. Triterpenes. XXL. 3,4-Seco derivatives of betulinic acid. Coll Czechoslov Chem Commun 1972;37:603-609.
56. Kim DSHL, Pezzuto JM, Pisha E. Synthesis of betulinic acid derivatives with activity against human melanoma. Bioorg Med Chem Lett 1998;8:1707-1712.
57. Miskiniene V, Dickancaite E, Nemeikaite A, Cenas N. Nitroaromatic betulin derivatives as redox cycling agents. Biochem Mol Biol Int 1997;42:391-397.
58. Kashiwada Y, Chiyo J, Ikeshiro Y, Nagao T, Okabe H, Cosentino LM, Fowke K, Morris-Natschke SL, Lee KH. Synthesis and anti-HIV activity of 3-alkylamido-3-deoxy-betulinic acid derivatives. Chem Pharm Bull 2000;48:1387-1390.
59. Sun IC, Wang HK, Kashiwada Y, Shen JK, Cosentino LM, Chen CH, Yang LM, Lee KH. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents. J Med Chem 1998;41:4648-4657.
60. Evers M, Poujade C, Soler F, Ribeill Y, James C, Lelievre Y, Gueguen J-C, Reisdorf D, Morize I, Pauwels R, De Clercq E, Henin Y, Bousseau A, Mayaux J-F, Le Pecq J-B, Dereu N. Betulinic acid derivatives: A new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action. J Med Chem 1996;39:1056-1068.
61. Kim JY, Koo HM, Kim DSHL. Development of C-20 modified betulinic acid derivatives as antitumor agents. Bioorg Med Chem Lett 2001;11:2405-2408.
62. Jeong HJ, Chai HB, Park SY, Kim DSHL. Preparation of amino acid conjugates of betulinic acid with activity against human melanoma. Bioorg Med Chem Lett 1999;9:1201-1204.
63. Pathak A, Singh SK, Biabani MAF, Kulshreshtha DK, Puri SK, Srivastava S, Kundu B. Synthesis of combinatorial libraries based on terpenoid scaffolds. Combin Chem High Throughput Screen 2002;5:241-248.
64. Fujioka T, Kashiwada Y, Kilkuskie RE, Cosentino LM, Ballas LM, Jiang JB, Janzen WP, Chen I-S, Lee KH. Anti-AIDS agents. 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenes. J Nat Prod 1994;57:243-247.
65. Mayaux JF, Bousseau A, Pauwels R, Huet T, Henin Y, Dereu N, Evers M, Soler F, Poujade C, De Clercq E, Le Pecq J-B. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Proc Natl Acad Sci USA 1994;91:3564-3568.
66. Sun I-C, Shen J-K, Wang H-K, Cosentino LM, Lee KH. Anti-AIDS agents. 32. Synthesis and anti-HIV activity of betulin derivatives. Bioorg Med Chem Lett 1998;8:1267-1272.
67. Ma C, Nakamura N, Miyashiro H, Hattori M, Shimotohno K. Inhibitory effects of constituents from Cynomorium songaricum and related triterpene derivatives on HIV-1 protease. Chem Pharm Bull 1999; 47:141-145.
68. Labrosse B, Pleskoff O, Sol N, Jones C, Henin Y, Alizon M. Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41. J Virol 1997;71: 8230-8236.
69. Soler F, Poujade C, Evers M, Carry J-C, Henin Y, Bousseau A, Huet T, Pauwels R, De Clercq E, Mayaux JF, Le Pecq JB, Dereu N. Betulinic acid derivatives: A new class of specific inhibitors of human immunodeficiency virus type 1 entry. J Med Chem 1996;39:1069-1083.
70. Holz-Smith SL, Sun IC, Jin L, Matthews TJ, Lee KH, Chen CH. Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of betulinic acid derivative IC9564. Antimicrob Agents Chemother 2001;45:60-66.
71. Sun IC, Chen CH, Kashiwada Y, Wu JH, Wang HK, Lee KH. Anti-AIDS agents. 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogs based on betulinic acid. J Med Chem 2002;45:4271-4275.
72. Hashimoto F, Kashiwada Y, Cosentino LM, Chen C-H, Garrett PE, Lee KH. Anti-AIDS agents. XXVII. Synthesis and anti-HIV activity of betulinic acid derivatives. Bioorg Med Chem 1997;5:2133-2143.
73. Kanamoto T, Kashiwada Y, Kanbara K, Gotoh K, Yoshimori M, Goto T, Sano K, Nakashima H. Antihuman immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Antimicrob Agents Chemother 2001;45:1225-1230.
74. Neamati N. A small-molecule antagonist of viron assembly. Expert Opin Invest Drugs 2001;10:1767-1770.
75. Lee KH, Morris-Natschke SL. Recent advances in the discovery and development of plant-derived natural products and their analogs as anti-HIV agents. Pure Appl Chem 1999;71:1045-1051.
76. De Clercq E. New developments in anti-HIV chemotherapy. Curr Med Chem 2001;8:1543-1572.
77. Kashiwada Y. Studies on bioactive natural products: Plant-derived natural products and analogs as anti-HIV agents. Nat Med 1999;53:153-158.
78. Schmidt ML, Kuzmanoff KL, Ling-Indeck L, Pezzuto JM. Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur J Cancer 1997;33:2007-2010.
79. Zuco V, Supino R, Righetti SC, Cleris K, Marchesi E, Gambacorti-Passerini C, Formelli F. Selective cytotoxicity of betulinic acid on tumor cell lines, but not normal cells. Cancer Lett 2002;175: 17-25.
80. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME, Debatin KM. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 1997;57:4956-4964.
81. Selzer E, Pimentel E, Wacheck V, Schlegel W, Pehamberger H, Jansen B, Kodym R. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J Invest Dermatol 2000;114:935-940.
82. Rieber M, Rieber MS. Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma. DNA Cell Biol 1998;17:399-406.
83. Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME, Debatin K-M. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 1998;273: 33942-33948.
84. Fulda S, Debatin KM. Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med Pediatr Oncol 2000;35:616-618.
85. Noda Y, Kaiya T, Kohda K, Kawazoe Y. Enhanced cytotoxicity of some triterpenes toward leukemia L1210 cells cultured in low pH media: Possibly a new mode of cell killing. Chem Pharm Bull 1997;45:1665-1670.
86. Wachsbeberger PR, Burd R, Wahl ML, Leeper DB. Betulinic acid sensitization of low pH adapted human melanoma cells to hyperthermia. Int J Hyperthermia 2002;18:153-164.
87. Melzig MF, Bormann H. Betulinic acid inhibits aminopeptidase N activity. Planta Med 1998;64:655-657.
88. Kwon HJ, Shim JS, Kim JH, Cho HY, Yum YN, Kim SH, Yu J. Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells. Jpn J Cancer Res 2002;93:417-425.
89. Salti GI, Kichina JV, Das Gupta TK, Uddin S, Bratescu L, Pezzuto JM, Mehta RG, Constantinou AI. Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocyte naeval cells: Evidence for a potential role as a chemopreventive agent. Melanoma Res 2001;11:99-104.
90. Ma J, Starck SR, Hecht SM. DNA polymerase β inhibitors from Tetracera boiviniana. J Nat Prod 1999;62:1660-1663.
91. Syrovets T, Buchele B, Gedig E, Slupsky JR, Simmet T. Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerase I and IIα. Mol Pharm 2000;58:71-81.
92. Yasukawa K, Takido M, Matsumoto T, Takeuchi M, Nakagawa S. Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter, and sitosterol and betulinic acid inhibit tumor promotion in mouse skin two-stage carcinogenesis. Oncology 1991;48:72-76.
93. Yasukawa K, Yu SY, Yamanouchi S, Takido M, Akihisa T, Tamura T. Some lupane-type triterpenes inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Phytomedicine 1995;4:309-313.
94. 32P-incorporation into phospholipids of HeLa cells promoted by 12-O-tetradecanoylphorbol-13-acetate. Phytomedicine 1999;6:73-77.
95. Hata K, Hori K, Takahashi S. Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line. J Nat Prod 2002;65:645-648.
96. Lee JS, Min BS, Bae KH. Cytotoxic constituents from the Forsythiaefructus against L1210 and HL60 cells. Yakhak Hoeji 1996;40:462-467.
97. Ye YY, He DW, Ye WC, Zhang QW, Zhao SX. Differentiation of B16 melanoma cells induced by 23-hydroxyl betulinic acid. Chin J Biochem Pharm 2001;22:163-166.
98. Safayhi H, Sailer E-R. Anti-inflammatory actions of pentacyclic triterpenes. Planta Med 1997;63:487-493.
99. Min B, Lee GI, Ha JY, Min KR, Kim JS, Kang SS, Kim Y. Inhibitory effects of triterpenoids on interleukin-8/CINC-1 induction in LPS-stimulated rat peritoneal macrophages. Nat Prod Sci 1996;2:48-55.
100. Ha JY, Min KR, Kang SH, Kim JS, Lee GI, Kang SS, Kim Y. Suppressive effects of triterpenoids on CINC-1 induction in interleukin-1β-stimulated rat fibroblast NRK-49F cells. Arch Pharm Res 1997;20:234-238.
101. Manez S, Recio MC, Giner RM, Rios J-L. Effect of selected triterpenoids on chronic dermal inflammation. Eur J Pharmacol 1997;334:103-105.
102. Huguet A-I, Recio MC, Manez S, Giner RM, Rios J-L. Effect of triterpenoids on the inflammation induced by protein kinase C activators, neuronally acting irritants and other agents. Eur J Pharmacol 2000;410:69-81.
103. Chang CW, Wang JP, Wu PP, Kuo SC, Chao PDL. Terpenoids from Ocium basilicum. Chin Pharm J 1999;51:181-189.
104. Krogh R, Kroth R, Berti C, Madeira AO, Souza MM, Cechinel-Filho V, Delle-Monache F, Yunes RA. Isolation and identification of compounds with antinociceptive action from Ipomoea pes-caprae (L.) R. Br. Pharmazie 1999;54:464-466.
105. Yamashita K, Lu H, Lu J, Chen G, Yokoyama T, Sagara Y, Manabe M, Kodama H. Effects of three triterpenoids, lupeol, betulin, and betulinic acid on the stimulus-induced superoxide generation and tyrosyl phosphorylation of proteins in human neutrophils. Clin Chim Acta 2002;325:91-96.
106. Jeong T-S, Hwang E-I, Lee H-B, Lee E-S, Kim Y-K, Min B-S, Bae K-H, Bok S-H, Kim S-U. Chitin synthase II inhibitory activity of ursolic acid, isolated from Crataegus pinnatifida. Planta Med 1999;65:261-263.
107. Wachter GA, Valcic S, Flagg ML, Franzblau SG, Montenegro G, Suarez E, Timmermann BN. Antitubercular activity of pentacyclic triterpenoids from plants of Argentina and Chile. Phytomedicine 1999;6:341-345.
108. Steele JCP, Warhurst DC, Kirby GC, Simmonds MSJ. In vitro and in vivo evaluation of betulinic acid as an antimalarial. Phytother Res 1999;13:115-119.
109. Bejar E, Amarquaye A, Che C-T, Malone MH, Fong HHS. Constituents of Byrsonima crassifolia and their spasmogenic activity. Int J Pharmacog 1995;33:25-32.
110. Ryu SY, Lee CK, Ahn JW, Lee SH, Zee OP. Antiviral activity of triterpenoid derivatives. Arch Pharm Res 1993;16:339-342.
111. Wang BH, Polya GM. Selective inhibition of cyclic AMP-dependent protein kinase by amphiphilic triterpenoids and related compounds. Phytochemistry 1996;41:55-63.
112. Purohit MC, Rawat MSM, Pant G. Spermicidal activity and chemical analysis of Schefflera venulosa. Fitoterapia 1993;64:274-275.
113. Stekhova SI, Samoshina NF, Denisenka MV, Denisenka VA, Logachev VV, Anisimov MM, Uvarova NI. Structural and functional properties of triterpenoids from the lupane series-I. Influence of betulinic acid and 3-O-glucoside of betulinic and dihydrobetulinic acids on root growth of Cucumis sativus L. seedlings. Rastitel'nye Resursy 2002;38:92-99.
114. Son LB, Kaplun AP, Symon AV, Shpilevsky AA, Grigoriev VB, Shvets VI. Solubilization of betulinic acid, a new antimelanoma compound. Proceed Int Symp Control Rel Bioact Mater 1998;25:419-420.
115. 2O. Oriental J Chem 2001;16:393-398.
116. Udeani GO, Zhao G-M, Shin YG, Cooke BP, Graham J, Beecher CWW, Kinghorn AD, Pezzuto JM. Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice. Biopharm Drug Dispos 1999;20:379-383.
117. Clark AM, Hufford CD. Use of microorganisms for the study of drug metabolism: An update. Med Res Rev 1991;11:437-501.
118. Akihisa T, Takamine Y, Yoshizumi K, Tokuda H, Kimura Y, Ukiya M, Nakahara T, Yokochi T, Ichiishi E, Nishino H. Microbial transformations of two lupane-type triterpenes and anti-tumor-promoting effects of the transformation products. J Nat Prod 2002;65:278-282.
119. Lewis DFV, Kouzi SA. Unpublished results.
120. Lewis DFV, Dickins M, Weaver RJ, Eddershaw PJ, Goldfarb PS, Tarbit MH. Molecular modeling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: Rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily. Xenobiotica 1998;28:235-268.
121. 2+ levels in Madin Darby canine kidney cells. Eur J Pharmacol 2000;408:99-106.